Effective postponement of diabetic nephropathy with enalapril in normotensive type 2 diabetic patients with microalbuminuria

Diabetes Care

Volumn 20, Issue 10, 1997, Pages 1576-1581

  Ahmad, Jamal ^a   Siddiqui, Mohammad A ^a   Ahmad, Habib ^a  

^a ALIGARH MUSLIM UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; INSULIN; ORAL ANTIDIABETIC AGENT; PLACEBO; UREA;

ADULT; ARTICLE; BLOOD PRESSURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIET THERAPY; DRUG EFFICACY; FEMALE; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HUMAN; KIDNEY PLASMA FLOW; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE;

EID: 0030770447     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.20.10.1576     Document Type: Article

References (53)

1. Viberti GC, Jarrett RJ, Mahmud U, Hill RD, Argyropoulos A, Mahamud U, Keen H: Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet i: 1430-1432, 1982
2. Mogensen CE, Christensen CK: Predicting diabetic nephropathy in insulin dependent patients. N Engl J Med 311:89-93, 1984
3. Mogensen CE: Microalbuminuria predicts clinical proteinuria and early mortality in maturity onset diabetes. N Engl J Med 310:356-360, 1984
4. Andersen AR, Christiansen JS, Andersen JK, Kernner S, Decken T: Diabetic nephropathy in type I (insulin-dependent) diabetes: an epidemiological study. Diabetologia 14:363-370, 1978
5. Parving H-H, Smidt UM, Frusberg B, Bonnevie-Nielsen U, Andersen AR: A prospective study of glomerular filtration rate and arterial blood pressure in insulin-dependent diabetics with diabetic nephropathy. Diabetologia 20:457-461, 1981
6. Klein R, Klein BE, Moss S, DeMets DL: Proteinuria in diabetes. Arch Intern Med 148:181-186, 1988
7. Rettig B, Teutsch SM: The incidence of end stage renal disease in type I and type II diabetes mellitus. Diabetic Nephropathy 3:26-27, 1984
8. Nelson RG, Newman JM, Knowler WC, Slevers ML, Kunzelman CL, Pettitt DJ, Moffett CD, Teutsch SM, Bennett PH: Incidence of end-stage renal disease in type II (non-insulin-dependent) diabetes mellitus in Pima Indians. Diabetologia 31:730-736, 1988
9. Mogensen CE: Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy. Br Med J 285:685-688, 1982
10. Parving HH, Anderson AR, Smidt UM, Svendsen PA: Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy. Lancet i:1175-1179, 1983
11. Parving HH, Andersen AR, Smidt UM, Hommel E, Mathiesen ER, Svendsen PA: Effect of antihypertensive treatment on kidney function in diabetic nephropathy. Br Med J 294:1443-1447, 1987
12. Ravid M, Savin H, Lang R, Jutrin I, Ludvinovsky S, Lishner M: Proteinuria, renal impairment, metabolic control and blood pressure in type 2 diabetes mellitus: a 14-year follow-up report on 195 patients. Arch Intern Med 152:1225-1229, 1992
13. Parving HH, Hommel E, Smidt UM: Protection of kidney function and decrease in albuminuria by captopril in insulin dependent diabetics with nephropathy Br Med J 297:1086-1091, 1988
14. Bjorck S, Mulec H, Johnsen SA, Norden G, Aurell M: Renal protective effect of enalapril in diabetic nephropathy. BMJ 304:339-343, 1992
15. Ueda Y, Aoi W, Yamachika SH, Shikaya T: Beneficial effects of angiotensin-converting enzyme inhibitor on renal function and glucose homeostasis in diabetics with hypertension. Nephron 55 (Suppl. 1):85-89, 1990
16. Mathiesen ER, Hommel E, Gliese J, Parving H-H: Efficacy of captopril in postponing nephropathy in normotensive insulin dependent diabetic patients with microalbuminuria. BMJ 303:81-87, 1991
17. Marre M, Chatellier G, Leblane H, Guyene TT, MenardJ, Passa P: Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria. Br Med J 297:1092-1095, 1988
18. Ravid M, Savin H, Jutrin I, Rental T, Katz B, Lishner M: Long-term stabilizing effect of angiotensin converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients. Ann Intern Med 118:577-581, 1993
19. Mathiesen ER, Hommel E, Smith U, Parving H-H: Efficacy of captopril in normotensive diabetic patients with microalbuminuria: 8 years follow-up (Abstract). Diabetologia 38 (Suppl. 1):A46, 1995
20. Laffel LMB, McGill JB, Gans DJ: The beneficial effect of angiotensin-converting enzyme inhibition with captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuira. Am J Med 99:497-504, 1995
21. Rodby RA, Lewis EJ, Firth LM, the Collaborative Study Group: An economic analysis of captopril in the treatment of diabetic nephropathy Diabetes Care 19:1051-1061, 1996
22. The Microalbuminuria Captopril Study Group: Captopril reduces the risk of nephropathy in IDDM patients with microalbuminuria. Diabetologia 39:587-593, 1996
23. The EUCLID Study Group: The effect of lisinopril on albumin excretion rate in nonhypertensive insulin dependent diabetes (IDDM) patients (Abstract). Diabetologia 39 (Suppl. 1):A42, 1996
24. World Health Organization: Diabetes Mellitus: Report of a WHO Study Group. Geneva, World Health Org., p. 1-113 (Tech. Rep. Ser., no. 727)
25. Rose GA: The diagnosis of ischaemic heart disease and intermittent claudication in field surveys. WHO Bull 27:645-658, 1962
26. Shortt S: Statistics for Health Professionals. Philadelphia, Saunders, 1990, p. 57-60
27. King EJ: Determination of effective renal plasma flow and glomerular filtration rate. In Microanalysis in Medical Biochemistry. Wootton IDP, Ed. London, Churchill, 1954, p. 223-232
28. 1C. FEBS Lett 71:356-360, 1976
29. Heinegard D, Tidestrom G: Determination of serum creatinine by a direct colorimetric method. Clin Chim Acta 43:405, 1973
30. Doumas BT, Biggs HG: Determination of serum albumin. Stand Methods Clin Chim 7:175-188, 1972
31. Lie RF, Schmitz JM, Pierre KJ, Gochman N: Cholesterol oxidase based determination by continuous flow analysis of total and free cholesterol in serum. Clin Chim 22:1627-1630, 1976
32. Bucolo G, David H: Quantitative determination of serum triglycerides by use of enzymes. Clin Chem 19:475-482, 1973
33. Lopes-Virella MF, Stone P, Ellis S, Colwell JA: Cholesterol determinations in high density lipoproteins separated by three different methods. Clin Chem 23:882-884, 1977
34. Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultra-centrifuge. Clin Chem 18:499-502, 1972
35. Matoni BJ, Steinman TI, Mitch WE: A method for estimating nitrogen intake of patients with chronic renal failure. Kidney Int 27:58-65, 1985
36. Isaksson B: Urinary nitrogen output as a validity test in dietary surveys. Am J Clin Nutr 33:4-5, 1982
37. Mogensen CE: Glomerular filtration rate and renal plasma flow in short-term and long-term juvenile diabetes mellitus. Scand J Clin Lab Invest 28:91-100, 1971
38. Ferder LF, Inserra F, Daccordi H, Smith RD: Enalapril improved renal function and proteinuria in chronic glomerulopathies. Nephron 55 (Suppl 1):90-95, 1990
39. Apperloo AJ, de Zeeuw D, Slutter HE, de Jong PE: Differential effects of enalapril and atenolol on proteinuria and renal hemodynamics in non-diabetic renal disease. BMJ 303:821-824, 1991
40. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD, for the Collaborative Study Group: The effect of angiotensin-converting enzyme inhibition on diabetic nephropathy. N Eng J Med 329:1456-1462, 1993
41. Allawi J, Rao PV, Gilbert R, Scott G, Jarret RJ, Keen H, Viberti GC, Mather HM: Microalbuminuria in non-insulin dependent diabetes: its relevance in Indians compared with Europid patients. Br Med J 262:462-464, 1988
42. Zatz R, Dunn R, Meyer TW, Anderson S, Rennke HG, Brenner BM: Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest 77:1925-1930, 1986
43. Anderson S, Rennke HG, Garcia DL, Brenner BM: Short-term and long-term effects of antihypertensive therapy in the diabetic rat. Kidney Int 36:526-536, 1989
44. Hostetter TH, Rennke HG, Brenner BM: The case for intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathies. Am J Med 72:375-380, 1982
45. Gansevoort RT, deZeeuw D, dejong PE: Dissociation between the course of the hemodynamic and anti-proteinuria effects of angiotensin-1-converting enzyme inhibition. Kidney Int 44:579-584, 1993
46. Minaram A, Insua A, Ribstein J, Monnier L, Bringer J, Mirouze J: Contrasting effect of captopril and nifedipine in normotensive patients with incipient diabetic nephropathy. J Hypertension 6:919-929, 1988
47. Slomowitz LA, Bergamo R, Grovenor M, Kopple JD: Enalapril reduces albumin excretion in diabetic patients with low levels of microalbuminuria. Am J Nephrol 10:457-462, 1990
48. Tuck M, Corry D: Hypertension and its management. In The Kidney in Diabetes Mellitus. Brenner BM, Ebstein JH, Eds. New York, Churchill Livingstone, 1989, p. 115-144
49. Jenkins DAS, Cowan P, Collier A, Watson ML, Clark BF: Blood glucose control determines the renal hemodynamic response to angiotensin-converting enzyme inhibition in type I diabetes. Diabet Med 7:252-257, 1990
50. Siegel JE, Krolewski AS, Warram JH, Weinstein MC: Cost-effectiveness of screening and early treatment of nephropathy in patients with insulin-dependent diabetes mellitus. J Am Soc Nephrol 3 (Suppl.):S111-S119, 1992
51. Borch-Johnsen K, Wengel H, Viberti GC, Mogensen CE: Is screening and intervention for microalbuminuria worthwhile in patients with insulin-dependent diabetes. BMJ 306:1722-1723, 1993
52. Viberti GC, on behalf of the Microalbuminuria Collaborative Study Group: Intensive therapy fails to prevent overt nephropathy in insulin dependent diabetics with microalbuminuria (Abstract). Diabetologia 37:A196, 1994
53. Laffel L, Warram J, Krolewski A: Glycemic control does not predict progression from low to high microalbuminuria (MA) in insulin-dependent diabetes (IDDM) (Abstract). J Am Soc Nephrol 5:379, 1994